贝泰妮：云南贝泰妮生物科技集团股份有限公司2023年年度报告_英文版.PDF

1、Yunnan Botanee Bio-Technology Group Co.,Ltd.2023 Annual Report 1 Yunnan Botanee Bio-Technology Group Co.,Ltd.2023 Annual Report 2024-011 April,2024 Yunnan Botanee Bio-Technology Group Co.,Ltd.2023 Annual Report 2 2023 Annual Report Section I Important Notice,Table of Contents,and Definitions Our Boa

2、rd of Directors,Board of Supervisors,directors,supervisors,and senior managers guarantee that this annual report is true,accurate and complete without falsehoods,misleading statements or major omissions,and undertake individual and joint legal liabilities arising therefrom.Our Chairman and President

3、 Mr.Guo Zhenyu,CFO Mr.Wang Long,and Head of Accounting Department Mr.Liu Zhaofeng hereby declare that the financial statements herein are true,accurate,and complete.All directors of Botanee have attended the board meeting for deliberating on this report.Forward-looking statements herein on Botanees

4、future prospects,business plans,etc.do not constitute substantial commitments to investors.Investors are advised to read carefully such information,and watch investment risks.Investors and related parties should maintain adequate risk awareness,and understand the differences between plans,forecasts,

5、and commitments.We have described in detail possible risks in our operations and our countermeasures in“Section III Management Discussion and Analysis”and“Section XI Future Prospects of Botanee”of this report.Investors are kindly requested to pay attention to these sections.Yunnan Botanee Bio-Techno

6、logy Group Co.,Ltd.2023 Annual Report 3 Our profit-sharing plan deliberated on and adopted by the Board of Directors is:to distribute CNY6.00 of cash dividend for every 10 shares to all shareholders based on 420,605,382 shares,give them 0 bonus shares(tax included),and issue 0 shares for them for ev